| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0008 |